Potential cardioprotective actions of no-releasing aspirin

Nat Rev Drug Discov. 2002 May;1(5):375-82. doi: 10.1038/nrd794.

Abstract

The use of low doses of aspirin on a daily basis has increased greatly in the past 20 years, based on observations that it can significantly reduce the risk of heart attacks and strokes. However, aspirin can also cause severe damage to the stomach. A modified version of aspirin that releases nitric oxide has been developed that seems to offer important advantages over its 103-year-old parent--namely, improved protection for the heart without the unwanted effects on the stomach.

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Arteriosclerosis / drug therapy
  • Aspirin / analogs & derivatives
  • Aspirin / pharmacology*
  • Aspirin / therapeutic use
  • Caspase Inhibitors
  • Cell Adhesion / drug effects
  • Cyclic GMP / physiology
  • Cytokines / biosynthesis
  • Heart / drug effects*
  • Humans
  • Hypertension / drug therapy
  • Myocardial Infarction / prevention & control*
  • Stroke / prevention & control*

Substances

  • Caspase Inhibitors
  • Cytokines
  • nitroaspirin
  • Cyclic GMP
  • Aspirin